RT Book, Section
A1 Chesnutt, Asha N.
A1 Chesnutt, Mark S.
A1 Prendergast, Niall T.
A1 Prendergast, Thomas J.
A2 Papadakis, Maxine A.
A2 McPhee, Stephen J.
A2 Rabow, Michael W.
SR Print(0)
ID 1175807983
T1 Alveolar Hemorrhage Syndromes
T2 Current Medical Diagnosis & Treatment 2021
YR 2021
FD 2021
PB McGraw-Hill Education
PP New York, NY
SN 9781260469868
LK accessmedicine.mhmedical.com/content.aspx?aid=1175807983
RD 2022/01/22
AB Diffuse  alveolar  hemorrhage  may  occur  in  a  variety  of  immune  and  nonimmune  disorders.  Alveolar  infiltrates  on  chest  radiograph,  dyspnea,  anemia,  hemoptysis,  and  occasionally  fever  are  characteristic.  Rapid  clearing  of  diffuse  lung  infiltrates  within  2  days  is  a  clue  to  the  diagnosis  of  diffuse  alveolar  hemorrhage  (eFigure  9–26).  Pulmonary  hemorrhage  can  be  associated  with  an  increased  single-breath  diffusing  capacity  for  carbon  monoxide  (DLCO).